Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00367393
Status:
COMPLETED
Last Update Posted:
2017-02-24
First Post:
2006-08-21
Brief Title:
Reconstitution With Pimecrolimus Cream 1 of Steroid-damaged Skin in Adults With Atopic Dermatitis
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
An Open-label Multicenter 12-month Long Term Study on Skin Reconstitution With Pimecrolimus Cream 1 in Adult Patients With Atopic Eczema and Corticosteroid Induced Skin Damage
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Topical steroid use may lead to skin deterioration and spider veins This study will examine long-term management of atopic dermatitis AD over 12 months with pimecrolimus cream 1 and its effect on skin reconstitution of steroid-damaged skin and disease control
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None